Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins
- Type
- Retraction
- Notice date
- 4/1/2024 0:00
- Journal
- Oncology Reports
- Publisher
- Spandidos
- Notice DOI
- 10.3892/or.2024.8728
- Original paper DOI
- 10.3892/or.2017.5622
Reasons
- Duplication of/in Image
- Euphemisms for Duplication
- Investigation by Third Party
- Manipulation of Images
- Unreliable Data
- Upgrade/Update of Prior Notice(s)